Use of psychotropic drugs before pregnancy and the risk for induced abortion: population-based register-data from Finland 1996-2006

Gissler, Mika; Artama, Miia; Ritvanen, Annukka; Wahlbeck, Kristian
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p383
Academic Journal
Background: Some, though not all studies have reported an increased risk for mental health problems after an induced abortion. Problems with design and data have compromised these studies and the generalisation of their results. Methods: The Finnish Medication and Pregnancy database (N = 622 671 births and 114 518 induced abortions for other than fetal reasons) in 1996-2006 was utilised to study the use of psychotropic drugs in the three months before a pregnancy ending in a birth or an induced abortion. Results: In total 2.1% of women with a birth and 5.1% of women with an induced abortion had used a psychotropic medicine 0-3 months before pregnancy. Psychotropic drug users terminated their pregnancies (30.9%) more often than other pregnant women (15.5%). Adjustment for background characteristics explained one third of this elevated risk, but the risk remained significantly increased among users of psychotropic medicine (OR 1.94, 95% confidence intervals 1.87-2.02). A similar risk was found for first pregnancies (30.1% vs. 18.9%; adjusted OR 1.53, 95% confidence intervals 1.42-1.65). The rate for terminating pregnancy was the highest for women using hypnotics and sedatives (35.6% for all pregnancies and 29.1% for first pregnancies), followed by antipsychotics (33.9% and 36.0%) and antidepressants (32.0% and 32.1%). Conclusions: The observed increased risk for induced abortion among women with psychotropic medication highlighs the importance to acknowledge the mental health needs of women seeking an induced abortion. Further studies are needed to establish the impact of pre-existing differences in mental health on mental health outcomes of induced abortions compared to outcomes of pregnancies ending in a birth.


Related Articles

  • Factores ambientales y genéticos asociados al consumo de psicofármacos en mujeres adultas. Un estudio de gemelos de base poblacional. Rosagro Escámez, Francisco; González-Javier, Francisca; Ordoñana, Juan R. // Actas Espanolas de Psiquiatria;Jul/Aug2013, Vol. 41 Issue 4, p232 

    Introduction: Our objective is to determine the prevalence and factors associated to psychotropic medication consumption in a sample of adult females. Additionally, this study seeks to analyze the relative contribution of environmental and genetic factors to psychoactive medication use. Method:...

  • More questions than answers! Clinical dilemmas in psychopharmacology in pregnancy and lactation. Desai, Geetha; Babu, Girish N.; Rajkumar, Ravi P.; Chandra, Prabha S. // Indian Journal of Psychiatry;2009, Vol. 51 Issue 1, p26 

    Women in childbearing age frequently suffer from mental illness. Maternal psychiatric disorders may have a devastating impact on the fetus and the newborn. Thus treating or preventing relapse of these disorders during pregnancy and puerperium is a clinical and ethical duty with the necessity to...

  • Baby boosts mom's brain. Gallia, Katherine; Althoff, Susanne // Natural Health;May99, Vol. 29 Issue 4, p25 

    Cites a study which showed that hormones released during pregnancy and nursing enrich the part of a woman's brain involved in learning and memory. Improvement in mental abilities of pregnant and nursing mice.

  • First Abortion Clinic Opens On Irish Soil. McCORMACK, CLAIRE // America;11/12/2012, Vol. 207 Issue 14, p6 

    The article presents information on Ireland's first abortion clinic opened by Marie Stopes International in Belfast, Northern Ireland. It is stated that Northern Ireland has very strict regulations on abortion, and the procedure is completely illegal in the nation. The clinic will function...

  • Audit of short term outcomes of surgical and medical second trimester termination of pregnancy. Mauelshagen, Annamarie; Sadler, Lynn C.; Roberts, Helen; Harilall, Mahesh; Farquhar, Cynthia M. // Reproductive Health;2009, Vol. 6, p16 

    Background: As comparisons of modern medical and surgical second trimester termination of pregnancy (TOP) are limited, and the optimum method of termination is still debated, an audit of second trimester TOP was undertaken, with the objective of comparing the outcomes of modern medical and...

  • Escitalopram : a review of its use in the management of major depressive and anxiety disorders. Waugh, John; Goa, Karen L. // CNS Drugs;2003, Vol. 17 Issue 5, p343 

    Unlabelled: Escitalopram is the therapeutically active S-enantiomer of RS-citalopram, a commonly prescribed SSRI. The R-enantiomer is essentially pharmacologically inactive. Escitalopram 10 or 20 mg/day produced significantly greater improvements in standard measurements of...

  • Landmark publications in Psychopharmacology: the first 40 years. Miczek, Klaus A. // Psychopharmacology;2001, Vol. 153 Issue 4, p399 


  • CME QUIZ.  // Psychiatric Annals;Jul2007, Vol. 37 Issue 7, p538 

    A quiz about psychotropic drugs is presented.

  • AGI Report Misrepresents Science on Abortion and Women's Mental Health.  // National Right to Life News;Jun2006, Vol. 33 Issue 6, p16 

    Comments on the results of a study on abortion and its impact on women's mental health conducted by the Alan Guttmacher Institute. Role of abortion in the increased risk for anxiety, depression, sleep problems and suicidal behavior among women; Failure of the study to include adequate controls...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics